Oak Street Health (Oak Street Health) Cash Flow from Financing : $66 Mil (TTM As of Dec. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Oak Street Health Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2022, Oak Street Health paid $0 Mil more to buy back shares than it received from issuing new shares. It received $0 Mil from issuing more debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0 Mil from paying cash dividends to shareholders. It received $0 Mil on other financial activities. In all, Oak Street Health spent $0 Mil on financial activities for the three months ended in Dec. 2022.

Oak Street Health Cash Flow from Financing Historical Data

The historical data trend for Oak Street Health's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oak Street Health Cash Flow from Financing Chart

Oak Street Health Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Cash Flow from Financing

157.25

53.60

476.30

785.30

66.40

Oak Street Health Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Cash Flow from Financing	Get a 7-Day Free Trial												4.90	1.90	-0.70	63.50	1.70

Oak Street Health Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Oak Street Health's Cash from Financing for the fiscal year that ended in Dec. 2022 is calculated as:

	Cash Flow from Financing		(A: Dec. 2022 )
=	Issuance of Stock	+	Repurchase of Stock	+	Net Issuance of Debt	+	Net Issuance of Preferred Stock	+	Cash Flow for Dividends	+	Other Financing
=	0	+	0	+	72.3	+	0	+	0	+	-5.9
=	66

Oak Street Health's Cash from Financing for the quarter that ended in Dec. 2022 is:

	Cash Flow from Financing		(Q: Dec. 2022 )
=	Issuance of Stock	+	Repurchase of Stock	+	Net Issuance of Debt	+	Net Issuance of Preferred Stock	+	Cash Flow for Dividends	+	Other Financing
=	0	+	0	+	0	+	0	+	0	+	0
=	0

Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $66 Mil.

Oak Street Health (NYSE:OSH) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Oak Street Health's issuance of stock for the three months ended in Dec. 2022 was $0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Oak Street Health's repurchase of stock for the three months ended in Dec. 2022 was $0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Oak Street Health's net issuance of debt for the three months ended in Dec. 2022 was $0 Mil. Oak Street Health received $0 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Oak Street Health's net issuance of preferred for the three months ended in Dec. 2022 was $0 Mil. Oak Street Health paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Oak Street Health's cash flow for dividends for the three months ended in Dec. 2022 was $0 Mil. Oak Street Health received $0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Oak Street Health's other financing for the three months ended in Dec. 2022 was $0 Mil. Oak Street Health received $0 Mil on other financial activities.

Oak Street Health Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Oak Street Health's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Oak Street Health (Oak Street Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Oak Street Health Inc (NYSE:OSH) » Definitions » Cash Flow from Financing

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 W. Monroe Street, Suite 1200, Chicago, IL, USA, 60603

Website

https://www.oakstreethealth.com

Oak Street Health Inc is a fast-growing network of value-based, primary care centers for adults on Medicare. The company operates a healthcare model focused on the quality of care over the volume of services and assumes the full financial risk of its patients.

Executives

Regina M. Benjamin	director	51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Geoffrey M Price	director, officer: See Remarks	30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603
Robert Guenthner	officer: Chief Legal Officer	30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603
Timothy M Cook	officer: Chief Financial Officer	30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603
Brian Clem	officer: President, Clinical Operations	30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603
Griffin Myers	director, officer: See Remarks	30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603
Newlight Partners Lp	10 percent owner	C/O NEWLIGHT PARTNERS LP, 320 PARK AVENUE, NEW YORK NY 10022
Michael T Pykosz	director, officer: See Remarks	30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603
General Atlantic, L.p.	10 percent owner	55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055
General Atlantic (spv) Gp, Llc	10 percent owner	55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055
Cynthia Hiskes	officer: Chief Human Resources Officer	30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603
Gap Coinvestments V, Llc	10 percent owner	55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055
Kim Keck	director	30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603
Tamara Jurgenson	officer: Chief Growth Officer	30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603
Newlight Harbour Point Spv Llc	10 percent owner	C/O NEWLIGHT PARTNERS LP, 320 PARK AVENUE, NEW YORK NY 10022